We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

120 hedge funds and large institutions have $58.1M invested in Sanofi Contingent Value Rights in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 12 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $39.6M → $58.1M (+$18.5M)

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

3% more funds holding

Funds holding: 116 → 120 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

57% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 28

Holders
120
Holders Change
+4
Holders Change %
+3.45%
% of All Funds
3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
12
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$3.5M
2
PC
PointState Capital
New York
+$2.47M
3
FCM
Farallon Capital Management
California
+$1.35M
4
TAM
TFG Asset Management
Cayman Islands
+$904K
5
HCM
Highbridge Capital Management
New York
+$750K

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$1.97M
2
WA
Whitebox Advisors
Minnesota
-$1.68M
3
NGA
New Generation Advisors
Massachusetts
-$1.55M
4
BHMP
Bardin Hill Management Partners
New York
-$994K
5
Millennium Management
Millennium Management
New York
-$254K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
76
Sonora Investment Management
Arizona
$385 -$79 -234 -19%
SWA
77
Sutton Wealth Advisors
Florida
$128 – – –
MPWT
78
MassMutual Private Wealth & Trust
Connecticut
$17 +$15 +44 New
ECM
79
Estabrook Capital Management
New York
$5 – – –
BHMP
80
Bardin Hill Management Partners
New York
– -$994K -3,679,902 Closed
MCM
81
Moore Capital Management
New York
– -$199K -745,100 Closed
ACM
82
Akanthos Capital Management
California
– -$180K -667,000 Closed
DAM
83
Deltec Asset Management
New York
– -$135K -500,000 Closed
PC
84
Permanens Capital
New York
– -$31K -112,982 Closed
PP
85
Paloma Partners
Connecticut
– -$27K -100,000 Closed
PFS
86
Prospera Financial Services
Texas
– -$5K -20,000 Closed
RIL
87
Rothschild Investment LLC
Illinois
– -$4K -15,000 Closed
WAM
88
Wealthspire Advisors (Maryland)
Maryland
– -$271 -800 Closed
Fifth Third Bancorp
89
Fifth Third Bancorp
Ohio
– -$80 -235 -65%
HI
90
Hudock Inc
Pennsylvania
– -$73 -217 -83%
BIM
91
BlackRock Investment Management
Delaware
– -$34 -100 -54%
TWA
92
TCI Wealth Advisors
Arizona
– -$26 -78 -19%
WT
93
Whittier Trust
California
– -$17 -50 -4%
AIC
94
Ayalon Insurance Company
Israel
– +$2 +7 New
CPA
95
Clear Perspective Advisors
Illinois
– +$5 +14 New
PCFFS
96
Pacific Center for Financial Services
California
– +$5 +14 New
DADC
97
D.A. Davidson & Co
Montana
– +$9 +28 +3%
LTFS
98
Ladenburg Thalmann Financial Services
Florida
– +$11 +33 +1%
EA
99
Edge Advisors
Georgia
– +$24 +70 New
Northwestern Mutual Wealth Management
100
Northwestern Mutual Wealth Management
Wisconsin
– +$90 +265 New
1 2 3
4
5

GCVRZ Hedge Fund Activity: Q4 2016 in Review

120 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2016, worth a combined $58.1M — up 47% from $39.6M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GCVRZ positions and 13 closed out — a net gain of 4 holders — while 12 added to existing stakes and 28 trimmed.

The largest buyer was Stonehill Capital Management, adding an estimated $3.5M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $1.97M.

  • 120 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2016, up from 116 in Q3 2016.
  • Funds reported $58.1M of Sanofi Contingent Value Rights stock for Q4 2016, up 47% quarter-over-quarter.
  • 17 funds opened new Sanofi Contingent Value Rights positions in Q4 2016 and 13 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2016 was Stonehill Capital Management, an estimated $3.5M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $1.97M sold.

Based on aggregated 13F filings for Q4 2016.